Publications in collaboration with researchers from Hospital Universitario de Salamanca (21)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

    Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681

  3. Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials

    Haematologica, Vol. 108, Núm. 4, pp. 969-980

  4. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

    HemaSphere, Vol. 7, Núm. 1, pp. E818

  5. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Predictors of cardiovascular events and all-cause of death in patients with transfusion-dependent myelodysplastic syndrome

    British Journal of Haematology, Vol. 195, Núm. 4, pp. 536-541

2019

  1. Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient

    Clinical Drug Investigation, Vol. 39, Núm. 11, pp. 1125-1131

2016

  1. Gene–gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients

    Drug Metabolism and Pharmacokinetics, Vol. 31, Núm. 5, pp. 349-355

  2. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma

    Annals of Hematology, Vol. 95, Núm. 2, pp. 253-262

  3. Natural resistance to Meningococcal Disease related to CFH loci: Meta-analysis of genome-wide association studies

    Scientific Reports, Vol. 6

2015

  1. Association between SNPs of metalloproteinases and prostaglandin f2α receptor genes and latanoprost response in open-angle glaucoma

    Ophthalmology, Vol. 122, Núm. 5, pp. 1040-1048.e4

2014

  1. Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients

    Personalized Medicine, Vol. 11, Núm. 7, pp. 693-704

  2. Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients

    Personalized Medicine, Vol. 11, Núm. 3, pp. 263-272

2013

  1. First symposium of ichthyosis experts

    Actas Dermo-Sifiliograficas

  2. Impact of pharmacogenetics on CNS side effects related to efavirenz

    Pharmacogenomics, Vol. 14, Núm. 10, pp. 1167-1178

  3. Pharmacogenetic analysis of SNPs in genes involved in the pharmacokinetics and response to lopinavir/ritonavir therapy

    Current Drug Metabolism, Vol. 14, Núm. 7, pp. 729-737

2012

  1. Shorter telomere length is associated with increased: Ovarian cancer risk in both familial and sporadic cases

    Journal of Medical Genetics, Vol. 49, Núm. 5, pp. 341-344

2010

  1. The genomics serving pediatrics in the investigation of the multifactorial disease

    Acta Pediatrica Espanola, Vol. 68, Núm. 2, pp. 55-60